Newsroom-Katalog
Zeit | Boehringer Ingelheim: Meldungen vom 18.11.2004 |
---|---|
12:11 | Boehringer Ingelheim Announces 24-Week Results From Second Phase III Pivotal Study of Tipranavir |
Zeit | Boehringer Ingelheim: Meldungen vom 18.11.2004 |
---|---|
12:11 | Boehringer Ingelheim Announces 24-Week Results From Second Phase III Pivotal Study of Tipranavir |